BackTevogen Bio Holdings Overview

Tevogen Bio Holdings Accounts Payable

Track Tevogen Bio Holdings's accounts payable ($2.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.83M
33.28% YoYΔ $-1.41M vs prior year quarter

Peer trimmed avg / median

Loading

Tevogen Bio Holdings Accounts Payable History

Loading

Tevogen Bio Holdings vs. peers: Accounts Payable Comparison

Loading

Tevogen Bio Holdings Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tevogen Bio Holdings (TVGN) FAQ

The latest accounts payable for TVGN is $2.8M as of June 2026. That compares with $4.2M in the prior-year period — down 33.3% year over year. Investors often review this figure alongside Tevogen Bio Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, TVGN's accounts payable moved from $4.2M to $2.8M — a 33.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tevogen Bio Holdings's operating scale or balance-sheet position.

A accounts payable figure of $2.8M for TVGN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TVGN's accounts payable ($2.8M), review year-over-year change from $4.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.